home technology applications about us news
deltaDOT Ltd. has been named as a partner in BARDA funded international consortium lead by  Texas A&M System Awarded National Center for Innovation. $285.6 million public-private  partnership has been allocated to enhance the nation’s biosecurity preparedness and create  jobs in Texas (see more opposite).
18 June 2012
30 January 2012 
deltaDOT Ltd., announced the signing of a distribution agreement with Kyokuto Boeki Kaisha  Ltd. of Tokyo, Japan, which covers the promotion and sales of deltaDOT’s analytical  instrument systems in Japan.
23rd October 2012 
deltaDOT sign distribution agreement with HORIBA UK   deltaDOT and HORIBA UK Ltd. of Stanmore, Middlesex have signed a distribution agreement,  with Horiba being appointed sole UK and Republic of Ireland distributor for deltaDOT HPCE  analytical instruments. "Being associated with a large player in the field of scientific instrumentation is very helpful, and  deltaDOT is expecting to benefit from HORIBA's brand, marketing expertise and from the field  support offered to deltaDOT technology by Horiba's sizeable engineering team" commented  deltaDOT's Managing Director Nigel Stokes. 
LABEL FREE INTRINSIC IMAGING LFII®
deltaDOT attended two conferences in Beijing - The Beijing Institute of Technology - PEPCon  2012 and the Beijing Institute of Technology -AnalytiX 2012. Also present were their Japanese  colleagues from KBK (Kyokuto Boeki Kaisha with staff from their Tokyo and Beijing offices.  Both KBK and deltaDOT were delighted with the response and interest in their Label Free  analytical technology and are currently following up significant leads from both booth visits and  post-presentation approaches. 
23 March 2012 
BioProcess International Awards nominated DARPA-AMP consortium (which includes  deltaDOT Ltd.) as one of the finalists in the category of "Collaboration of the Decade" for work  started in 2007 on the AMP project. BioProcess International formally introduced the 36 Award  finalists for 2012. This exclusive group represents the very best technologies, applications,  collaborations, and thought leaders that the bioprocessing industry has to offer (...more) 
24 September 2012
24th January 2017 – deltaDOT Ltd. announces compliance with CFR 21 part 11 of USA’s  Food and Drug Administration. deltaDOT now offers an upgraded version of its control and  analysis software which has been designed to aid users of deltaDOT’s HPCE-512 Hig  Performance Capillary Electrophoresis instrument in achieving compliance with CFR 21 part  11.The upgrade package contains controls to help meet the stringent requirements of CFR  21 part 11 including the system access by authorised personel only, maintaining audit trails  of user actions, generating complete and protected data files and the application of  electronic signatures to data (...more)  20 Sep 2016 National Health Service Quality Control North West (QCNW) Liverpool  labs  presented the data on monoclonal antibody stability trials based on deltaDOT’s Capillary  Electrophoresis (CE) technology  and expertise. They state that CE technology is suitable for  monitoring the stability of monoclonal antibodies and can perform purity and charge analysis  with high resolution and repeatability. They conclude that CE can replace other techniques  commonly used for this analysis IEC and SDS PAGE (link to the poster).  3rd July 2016 Monoclonal Antibody Stability Trials using deltaDOT HPCE-512 technology  reported by Dr. Deepika Devanur. Now available in pdf slide format on our website (...more)  4th March 2016, FDA CFR21/11 Compliance - deltaDOT’s progress continues with the  implementation of the software quality system while the P3 controller system management  software and the P3EVA analysis package had their compliance completed previously  deltaDOT engineers are working with Optra systems of California (...more)  26th January 2016, National Health Service Quality Control North West (QCNW) Liverpool  Labs are to perform monoclonal antibody stability trials, utilising deltaDOT Ltd. technology  and expertise to aid the study.     4th February 2016 Webinar: Improve your Monoclonal Antibodies Analysis. Live webinar  on analysing mAbs from production to patient. Given jointly by Horiba Scientific and  deltaDOT Ltd. Presented by Dr. Deepika Devanur (...registration site)  14th December 2015, deltaDOT technology used to define product quality for ImmBio  Ltd. deltaDOT Ltd (London) are pleased to announce that its Label Free Intrinsic Imaging  (LFII®) technology has been used to help ImmBio (Cambridge UK) to submit an  Investigational Medicinal Product Dossier (IMPD) as part of a clinical trial application to The  Medicines and Healthcare products Regulatory AgencMHRA (...more)  24th  November 2015, NW Labs are to market a kidney function test developed by  deltaDOT Ltd and the Royal Veterinary College. At the London Vet Show held at Olympia  on 19 and 20 Nov 2015 it was announced that NW Labs are now promoting deltaDOT’s  Glomerular filtration rate (GFR) assay for measuring kidney function in cats and dogs. NW  Labs will refer cases of suspected early stage renal disease for measurement by deltaDOT  with interpretation and advice on management by expert clinicians at the Royal Veterinary  College, London (...more) 12-14 March 2015, 2nd International Conference on Label-Free Technologies  Boston Marriott Cambridge, MA, USA. Dr. Stuart Hassard will be speaking on Label free  intrinsic imaging high performance capillary electrophoresis - a powerful tool in analytical  science. 4th, 5th March 2015 Keeping pace - Analytics for tomorrow’s biopharmaceuticals    conference, Leeds, UK. Dr. Stuart Hassard will be speaking on Label free intrinsic imaging  high performance capillary electrophoresis trends throughout biopharmaceutical process  analytical technology.